Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Targeting the gut to prevent sepsis from a cutaneous burn
Fatemeh Adiliaghdam, … , Laurence G. Rahme, Richard A. Hodin
Fatemeh Adiliaghdam, … , Laurence G. Rahme, Richard A. Hodin
Published October 2, 2020
Citation Information: JCI Insight. 2020;5(19):e137128. https://doi.org/10.1172/jci.insight.137128.
View: Text | PDF
Research Article Gastroenterology Microbiology

Targeting the gut to prevent sepsis from a cutaneous burn

  • Text
  • PDF
Abstract

Severe burn injury induces gut barrier dysfunction and subsequently a profound systemic inflammatory response. In the present study, we examined the role of the small intestinal brush border enzyme, intestinal alkaline phosphatase (IAP), in preserving gut barrier function and preventing systemic inflammation after burn wound infection in mice. Mice were subjected to a 30% total body surface area dorsal burn with or without intradermal injection of Pseudomonas aeruginosa. Mice were gavaged with 2000 units of IAP or vehicle at 3 and 12 hours after the insult. We found that both endogenously produced and exogenously supplemented IAP significantly reduced gut barrier damage, decreased bacterial translocation to the systemic organs, attenuated systemic inflammation, and improved survival in this burn wound infection model. IAP attenuated liver inflammation and reduced the proinflammatory characteristics of portal serum. Furthermore, we found that intestinal luminal contents of burn wound–infected mice negatively impacted the intestinal epithelial integrity compared with luminal contents of control mice and that IAP supplementation preserved monolayer integrity. These results indicate that oral IAP therapy may represent an approach to preserving gut barrier function, blocking proinflammatory triggers from entering the portal system, preventing gut-induced systemic inflammation, and improving survival after severe burn injuries.

Authors

Fatemeh Adiliaghdam, Paul Cavallaro, Vidisha Mohad, Marianna Almpani, Florian Kühn, Mohammad Hadi Gharedaghi, Mehran Najibi, Laurence G. Rahme, Richard A. Hodin

×

Figure 4

IAP attenuates liver inflammation and reduces the proinflammatory characteristics of portal serum after burn wound infection injury.

Options: View larger image (or click on image) Download as PowerPoint
IAP attenuates liver inflammation and reduces the proinflammatory charac...
(A) IL-6 levels in the liver of sham, burn wound–infected mice with or without IAP supplementation measured by ELISA. (B) Portal serum endotoxin levels measured by Limulus amebocyte lysate assay. (C and D) Tnfa and Il6 mRNA levels of primary mouse BMDMs incubated with systemic or portal serum of the designated groups for 24 hours as measured by qPCR. (E) Correlation between the gut permeability measured by FITC and the proinflammatory characteristics of portal serum measured by Il6 mRNA level in BMDMs. One-way ANOVA with multiple post hoc comparisons using Tukey’s test was performed for Figure 4, A–D. Pearson’s correlation coefficient was used in Figure 4E. Each group included 3–5 animals and data are representative of 3 biological replicates. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. IAP, intestinal alkaline phosphatase; BMDMs, bone marrow–derived macrophages.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts